Raj Mehra - 10 Jan 2022 Form 4 Insider Report for SEELOS THERAPEUTICS, INC. (SEEL)

Role: President, Chief Executive Officer and Chairman of the Board of Directors; Exhibit 24 - Power of Attorney, Director
Signature: /s/ Raj Mehra
Issuer symbol: SEEL
Transactions as of: 10 Jan 2022
Transactions value $: $0
Form type: 4
Filing time: 11 Jan 2022, 15:29:17 UTC
Previous filing: 10 Mar 2022
Next filing: 31 Mar 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SEEL	Stock Option (right to buy)	Award	$0	+1.3M		$0.00	1.3M	10 Jan 2022	Common Stock	1.3M	$1.46	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1/4th of the shares subject to the option shall vest on January 10, 2023, and 1/48th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Remarks:

President, Chief Executive Officer and Chairman of the Board of Directors; Exhibit 24 - Power of Attorney